Shares of Pfizer dropped 1.84% to $38.00 at 13:30 EST on Wednesday, after five consecutive sessions in a row of losses. The New York Stock Exchange is jumping 0.01% to $14,404.10, following yesterday’s upward trend, This seems, at the moment, a somewhat positive trend trading session today.

Pfizer’s last close was $38.71, 13.37% under its 52-week high of $43.08.

News about Pfizer today

Some Pfizer vaccine doses returned after getting too cold to use. According to today’s article on Bloomberg Quint, "Pfizer did not immediately respond to a request for comment.", "Pfizer has said its formula needs to be stored at 70 degrees below zero Celsius, the equivalent of negative 94 degrees below zero Fahrenheit. "

Pfizer’s Sales

Pfizer’s sales growth is a negative 9.7% for the present quarter and a decline by 0.5% for the next. The company’s growth estimates for the present quarter and the next is a negative 9.1% and a negative 8.8%, respectively.

Pfizer’s Revenue

Year-on-year quarterly revenue growth declined by 4.3%, now sitting on 48.65B for the twelve trailing months.

Pfizer’s Stock Top and Bottom Yearly Value

Pfizer’s stock is valued at $38.00 at 13:30 EST, way under its 52-week high of $43.08 and way above its 52-week low of $26.45.

Pfizer’s Moving Average

Pfizer’s worth is higher than its 50-day moving average of $37.29 and higher than its 200-day moving average of $35.20.

Previous days news about Pfizer

FDA nears Pfizer decision; Australia cancels order: virus update. According to Bloomberg Quint on Fri Dec 11, "White House Chief of Staff Mark Meadows said that FDA Commissioner Stephen Hahn’s job could be on the line if his agency doesn’t soon approve Pfizer Inc.’s coronavirus vaccine, according to a person familiar with the matter.", "A New York state panel of public-health advisers approved a Food and Drug Administration committee’s backing for emergency use authorization of the Pfizer Inc. and BioNTech SE vaccine, Governor Andrew Cuomo said on Twitter."

Pfizer vaccine clearance to be sought in Hong Kong after FDA nod. According to Bloomberg Quint on Fri Dec 11, "Fosun has yet to apply for authorization for the Pfizer-BioNTech vaccine’s use in mainland China. ", "The EU is also reviewing the Pfizer-BioNTech shot and is expected to authorize it soon."

Pfizer raises quarterly cash dividend to 39 cents a share vs. 38 cents. According to MarketWatch on Fri Dec 11, "Pfizer Inc. said Friday’s its board has raised its quarterly cash dividend to 39 cents a share from 38 cents in the year-earlier period. ", "”It is expected that Viatris will begin paying a quarterly dividend in the second quarter of 2021, at which time Pfizer’s quarterly dividend will be reduced such that the combined dividend dollar amount received by Pfizer shareholders, based upon the combination of continued Pfizer ownership and approximately 0.124079 shares of Viatris which were granted for each Pfizer share in the spin-off, will equate to Pfizer’s dividend amount in effect immediately prior to the initiation of the Viatris dividend,” the company said in a statement. "

FDA aiming for quick authorization of Pfizer covid vaccine. According to Bloomberg Quint on Fri Dec 11, "”That’s something we’re working with Pfizer right now on is the appropriate language for the doctors, is if you have a pre-existing serious allergic reaction to anything in these vaccines or medical allergies, you should exercise caution in getting these vaccines initially,” Azar said on Friday in an interview with Fox Business News.", "White House Chief of Staff Mark Meadows said that FDA Commissioner Stephen Hahn’s job could be on the line if his agency doesn’t soon approve Pfizer Inc.’s coronavirus vaccine, according to a person familiar with the matter."

Pfizer vaccine cleared in U.S., a landmark in Covid-19 fight. According to Bloomberg Quint on Sat Dec 12, "Among the vaccine front-runners, the Pfizer-BioNTech shot is the only one that didn’t take funding from the White House-led Operation Warp Speed program to accelerate development, manufacturing and distribution of Covid-19 shots. ", "Pfizer didn’t study the vaccine in pregnant or lactating women, though the FDA is leaving it up to those women as to whether they will receive the vaccine. "

Mexico approves Pfizer vaccine for emergency use as covid surges. According to Bloomberg Quint on Sat Dec 12, "Mexico’s health agency Cofepris approved Pfizer’s coronavirus vaccine for emergency use, Deputy Health Minister Hugo Lopez-Gatell said at a press conference Friday night.", "Mexico joins the U.K., Canada and the U.S. as countries that have granted emergency use of the Pfizer vaccine. "

Pfizer says prepared to deliver first doses of Covid-19 vaccine in U.S. immediately. According to Business Insider on Sat Dec 12, "Pfizer Inc. (PFE) and BioNTech SE (BNTX) said Friday that they will begin delivering the first doses of their COVID-19 vaccine in the U.S. immediately, with delivery fulfillment expected to be completed in 2021.", "Pfizer and BioNTech said that they are confident in their ability to deliver the vaccine to people in the U.S. Their combined manufacturing network has the potential to supply globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses by the end of 2021."

U.S. CDC committee of independent health experts recommends vaccination with Pfizer and biontech Covid-19 vaccine for persons ages 16 years and older. According to Business Insider on Sat Dec 12, "Collectively, we aim to vaccinate hundreds of millions of Americans by the end of 2021,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. ", "Pfizer Disclosure Notice"

Pfizer May offer shots to trial volunteers who received placebo. According to Bloomberg Quint on Mon Dec 14, "Vanchiere said he has vials of Pfizer’s vaccine stored in an ultra-cold freezer and could start administering the shots as soon as Monday, the same day the vaccine is expected to start being offered to health-care workers.", "Pfizer’s emergency use application provided data from 37,586 volunteers, the majority of whom were in the U.S., according to the FDA. "

US Covid-19 vaccinations to begin Monday as CDC recommends Pfizer vaccine. According to Business Insider on Mon Dec 14, "The CDC Director accepted the recommendation by CDC’s Advisory Committee on Immunization Practices or ACIP for vaccination with Pfizer-BioNTech COVID-19 vaccine in people 16 years of age and older. ", "The Pfizer Vaccine is authorized for use under EUA for active immunization to prevent covid-19 caused by severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2 in individuals 16 years of age and older."

Pfizer, biontech Covid-19 vaccine candidate study in Germany support safety profile. According to MarketWatch on Mon Dec 14, "Pfizer Inc. and its Germany-based partner BioNTech SE said overall results of a Phase 1/2 study in Germany of its COVID-19 vaccine candidate, BNT162b2, mirrored those from the U.S. study. ", "The study’s result come as the companies’ vaccine is being distributed for use in the U.S. Shares of Pfizer rose 1.5% in premarket trading and BioNTech’s stock gained 0.9%, as futures for the S&P 500 tacked on 0.6%."

Pfizer, biontech report data from German phase 1/2 trial with Covid-19 vaccine candidate. According to Business Insider on Mon Dec 14, "Pfizer Inc. (PFE) and BioNTech SE (BNTX) reported additional data on neutralizing antibody and T cell responses from the phase 1/2 trial with BNT162b2 conducted in Germany. ", "BNT162b2 is an investigational COVID-19 vaccine developed by Pfizer-BioNTech. "

LEAVE A REPLY

Please enter your comment!
Please enter your name here